NurExone Biologic (NRX) Price & Analysis

Compare

5 Followers

NRX Stock Chart & Stats

Day’s Range― - ―

52-Week RangeC$0.48 - C$0.87

Previous CloseN/A

VolumeN/A

Average Volume (3M)20.96K

Market Cap

C$42.14M

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)31.00K

Price to Earnings (P/E)―

Beta-0.43

Next Earnings

Sep 02, 2025

EPS Estimate

-0.03

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.02

Shares Outstanding59,357,914

10 Day Avg. Volume41,976

30 Day Avg. Volume20,956

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)0.00

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

C$2.61

Price Target Upside267.61% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering0

NurExone Biologic News

PremiumCompany Announcements

NurExone Advances ExoPTEN Manufacturing and Seeks Shareholder Approval for Omnibus Plan

3d ago

PremiumCompany Announcements

NurExone Biologic to Launch Clinical Trials for ExoPTEN in 2026

8d ago

PremiumCompany Announcements

NurExone Biologic Reports Q1 2025 Financials and Strategic Advancements

11d ago

PremiumCompany Announcements

NurExone Biologic Unveils Promising Preclinical Data on Optic Nerve Regeneration at ARVO 2025

30d ago

PremiumCompany Announcements

NurExone Biologic Expands European Engagement with Key Investor Events

1M ago

PremiumCompany Announcements

NurExone Unveils Breakthrough in Facial Nerve Regeneration at ISEV 2025

1M ago

PremiumCompany Announcements

NurExone Expands U.S. Operations with New Leadership and Ontario Continuance

2M ago

PremiumCompany Announcements

NurExone Biologic Secures C$2.3 Million Funding for U.S. Expansion and Uplisting Plans

2M ago

See All TSE:NRX News

See All News >

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

7.95% Insiders

―

Mutual Funds

― Other Institutional Investors

92.05% Public Companies and

Individual Investors

Detailed Ownership Overview >

NRX FAQ

What was Nurexone Biologic Inc.’s price range in the past 12 months?

Nurexone Biologic Inc. lowest stock price was C$0.47 and its highest was C$0.87 in the past 12 months.

What is Nurexone Biologic Inc.’s market cap?

Nurexone Biologic Inc.’s market cap is C$42.14M.

When is Nurexone Biologic Inc.’s upcoming earnings report date?

Nurexone Biologic Inc.’s upcoming earnings report date is Sep 02, 2025 which is in 87 days.

How were Nurexone Biologic Inc.’s earnings last quarter?

Nurexone Biologic Inc. released its earnings results on May 27, 2025. The company reported -C$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.02.

Is Nurexone Biologic Inc. overvalued?

According to Wall Street analysts Nurexone Biologic Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Nurexone Biologic Inc. pay dividends?

Nurexone Biologic Inc. does not currently pay dividends.

What is Nurexone Biologic Inc.’s EPS estimate?

Nurexone Biologic Inc.’s EPS estimate is -0.03.

How many shares outstanding does Nurexone Biologic Inc. have?

Nurexone Biologic Inc. has 59,357,914 shares outstanding.

What happened to Nurexone Biologic Inc.’s price movement after its last earnings report?

Nurexone Biologic Inc. reported an EPS of -C$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.515%.

Which hedge fund is a major shareholder of Nurexone Biologic Inc.?

Currently, no hedge funds are holding shares in TSE:NRX

NurExone Biologic Stock Smart Score

Neutral

Fundamentals

Return on Equity

-237.60%

Trailing 12-Months

Asset Growth

-45.05%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Nurexone Biologic Inc.

EnerSpar Corp is a Canada based company. Its business is the acquisition, exploration, and development of resource property especially in the field of industrial minerals. Its project includes the Johan Beetz Feldspar property.

NRX Stock 12 Month Forecast

Average Price Target

C$2.61

▲(267.61%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"C$0","1":"C$1","2":"C$2","3":"C$3","-1":"-C$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.61,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$2.61</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.61,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$2.61</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.61,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$2.61</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0,1,2,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2024","6":"Jul<br/>2024","9":"Oct<br/>2024","12":"Dec<br/>2024","25":"Dec<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.73,0.8746153846153846,1.0192307692307692,1.163846153846154,1.3084615384615383,1.4530769230769232,1.5976923076923077,1.7423076923076923,1.886923076923077,2.0315384615384615,2.176153846153846,2.3207692307692307,2.4653846153846155,{"y":2.61,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.73,0.8746153846153846,1.0192307692307692,1.163846153846154,1.3084615384615383,1.4530769230769232,1.5976923076923077,1.7423076923076923,1.886923076923077,2.0315384615384615,2.176153846153846,2.3207692307692307,2.4653846153846155,{"y":2.61,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.73,0.8746153846153846,1.0192307692307692,1.163846153846154,1.3084615384615383,1.4530769230769232,1.5976923076923077,1.7423076923076923,1.886923076923077,2.0315384615384615,2.176153846153846,2.3207692307692307,2.4653846153846155,{"y":2.61,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.29,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.3,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.7,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.78,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.6,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.52,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.75,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.63,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.58,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.58,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.67,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.73,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.73,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >